| Literature DB >> 23437374 |
Keding Cheng1, Mike Drebot, Joanne McCrea, Lorea Peterson, David Lee, Stuart McCorrister, Richard Nickel, Alyssia Gerbasi, Angela Sloan, Debra Janella, Gary Van Domselaar, Daniel Beniac, Tim Booth, Linda Chui, Helen Tabor, Garrett Westmacott, Matthew Gilmour, Gehua Wang.
Abstract
Serotyping is the long-standing gold standard method to determine E. coli H antigens; however, this method requires a panel of H-antigen specific antibodies and often culture-based induction of the H-antigen flagellar motility. In this study, a rapid and accurate method to isolate and identify the Escherichia coli (E. coli) H flagellar antigen was developed using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Flagella were isolated from pure culture, digested with trypsin, and then subjected to LC-MS/MS using one of two systems (Agilent-nano-LC-QSTAR XL or Proxeon-nano-LC-LTQ-Orbitrap XL). The resulting peptide sequence data were searched against a custom E. coli flagella/H antigen database. This approach was evaluated using flagella isolated from reference E. coli strains representing all 53 known H antigen types and 41 clinical E. coli strains. The resulting LC-MS/MS classifications of H antigen types (MS-H) were concordant with the known H serogroup for all 53 reference types, and of 41 clinical isolates tested, 38 (92.7%) were concordant with the known H serogroup. MS-H clearly also identified two clinical isolates (4.9%) that were untypeable by serotyping. Notably, successful detection and classification of flagellar antigens with MS-H did not generally require induction of motility, establishing this proteomic approach as more rapid and cost-effective than traditional methods, while providing equitable specificity for typing E. coli H antigens.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23437374 PMCID: PMC3578835 DOI: 10.1371/journal.pone.0057339
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
H7 identification of reference strains by MS-H with the QSTAR platforma.
| Strain number | MS-H type | Sequence coverage (%) | |
| Test 1 | Test 2 | ||
| EDL-933 | H7 | 72 | 68 |
| E175 | H7 | 72 | 86 |
| 06-1139 | H7 | 79 | 76 |
| 06-3122 | H7 | 80 | 90 |
| 07-0097 | H7 | 67 | 61 |
| 07-0918 | H7 | 61 | 74 |
| 07-1591 | H7 | 78 | 80 |
| 07-1756 | H7 | 75 | 88 |
| 07-1946 | H7 | 75 | 88 |
| 87-1215 | H7 | 82 | 87 |
| 90-2380 | H7 | 71 | 78 |
| E32511 (non-motile) | No flagellin detected | 0 | 0 |
11 known H7 positive E. coli strains and one non-motile strain (E32511) were twice tested for MS-H, and the sequence coverage were obtained by Mascot database search.
MS-H identification of all references strains with the QSTAR platforma.
| Recorded H serotype | Representative strain | MS-H types with no motility induced | MS-H type sequence coverage (%) | Number of strains tested by MS-H |
| H1 | E169 | H1 | 61 | 1 |
| H2 | E170 | H2 | 81 | 2 (1 UI) |
| H3 | E171 | H3 | 49 | 1 |
| H4 | E172 | H4 | 88 | 1 |
| H5 | E173 | H5 | 45 | 1 |
| H6 | E174 | H6 | 65 | 1 |
| H7 | E175 | H7 | 68 | 1 |
| H8 | E176 | H8 | 78 | 1 |
| H9 | E177 | H9 | 74 | 1 |
| H10 | E659 | H10 | 62 | 2 (1 UI) |
| H11 | 07-6285 | H11 | 70 | 2 (1 UI) |
| H12 | E241 | H12 | 47 | 1 |
| H14 | E182 | H14 | 89 | 1 |
| H15 | E183 | H15 | 93 | 1 |
| H16 | E184 | H16 | 81 | 1 |
| H17 | E185 | H17 | 87 | 1 |
| H18 | E186 | H18 | 30 | 3 (1 UI) |
| H19 | 09-0523 | H19 | 69 | 2 |
| H20 | E188 | H20 | 94 | 1 |
| H21 | E189 | H21 | 71 | 1 |
| H23 | E191 | H23 | 69 | 1 |
| H24 | E192 | H24 | 88 | 1 |
| H25 | E193 | H25 | 86 | 1 |
| H26 | E194 | H26 | 95 | 1 |
| H27 | E195 | H27 | 76 | 1 |
| H28 | E196 | H28 | 49 | 1 |
| H29 | E197 | H29 | 98 | 1 |
| H30 | E198 | H30 | 58 | 1 |
| H31 | E199 | H31 | 49 | 1 |
| H32 | E200 | H32 | 70 | 3 (1 UI) |
| H33 | E201 | H33 | 70 | 1 |
| H34 | E589 | H34 | 62 | 1 |
| H35 | E203 | H35 | 58 | 2 |
| H36 | E204 | H36 | 89 | 1 |
| H37 | E205 | H37 | 81 | 1 |
| H38 | E206 | H38 | 99 | 1 |
| H39 | E207 | H39 | 81 | 1 |
| H40 | E208 | H40 | 95 | 1 |
| H41 | E209 | H41 | 79 | 1 |
| H42 | E210 | H42 | 29 | 2 |
| H43 | E211 | H43 | 83 | 1 |
| H44 | E212 | H44 | 87 | 1 |
| H45 | E213 | H45 | 47 | 1 |
| H46 | E214 | H46 | 37 | 1 |
| H47 | E346 | H47 | 58 | 1 |
| H48 | E247 | H48 | 70 | 1 |
| H49 | E248 | H49 | 79 | 1 |
| H51 | E372 | H51 | 43 | 1 |
| H52 | E373 | H52 | 47 | 1 |
| H53 | E374 | H53 | 74 | 1 |
| H54 | E377 | H54 | 76 | 1 |
| H55 | E375 | H55 | 74 | 1 |
| H56 | E376 | H56 | 46 | 1 |
UI, unidentified strain.
Known reference strains encompassing all 53 H types were tested by MS-H. If a primary strain could not be identified after three consecutive MS-H analyses, an alternate strain was selected for MS-H typing.
Comparison of H serotyping and MS-H typing results for clinical isolates with the QSTAR platforma.
| Strain number | Motility | Serotypes with motility induced | MS-H (without motility induction) / sequence coverage | |
| H types | Sequence coverage (%) | |||
| 09-0409 | M | H28 | H28 | 50 |
| 09-0410 | M | H28 | H28 | 40 |
| 09-0411 | M | H11 | H11 | 58 |
| 09-0412 | M | H49 | H49 | 42 |
| 09-0413 | M | H16 | H16 | 53 |
| 09-0414 | M | H7 | H7 | 51 |
| 09-0415 | M | H8 | H8 | 38 |
| 09-0416 | M | H28 | H28 | 44 |
| 09-0417 | M | H7, then untypeable | H21b | 80 |
| 09-1340 | M | H11 | H11 | 52 |
| 09-1341 | M | H11 | H11 | 63 |
| 09-1342 | M | H11 | H11 | 57 |
| 09-1343 | M | H11 | H11 | 50 |
| 09-1344 | M | H11 | H11 | 52 |
| 09-1347 | M | H19 | H19 | 56 |
| 09-1348 | M | H19 | H19 | 41 |
| 09-1349 | M | H7 | H7 | 39 |
| 09-1350 | M | H7 | H7 | 45 |
| 09-1351 | M | H7 | H7 | 41 |
| 09-1352 | M | H7 | H7 | 39 |
| 09-1353 | M | H25 | H25 | 42 |
| 09-1354 | M | H25 | H25 | 28 |
| 09-1760 | M | untypeable | H21b | 71 |
| 09-1764 | M | H19 | H19 | 41 |
| 09-1765 | M | H11 | H11 | 77 |
| 09-1766 | M | H34 | H34 | 14 |
| 09-1767 | M | H11 | H11 | 72 |
| 09-1768 | M | H14 | H14 | 40 |
| 09-1769 | M | H14 | H14 | 65 |
| 09-1770 | M | H19 | H19 | 45 |
| 09-1774 | M | H19 | H19 | 49 |
| 09-1775 | M | H25, then rough | H4 | 8 |
| 09-2554 | M | H21 | H21 | 73 |
| 09-2555 | M | H21 | H21 | 72 |
| 09-2560 | M | H21 | H21 | 83 |
| 09-1336 | NM | UI | ||
| 09-1337 | NM | UI | ||
| 09-1338 | NM | UI | ||
| 09-1339 | NM | UI | ||
| 09-1345 | NM | UI | ||
| 09-1346 | NM | UI | ||
M, motile; NM, non-motile; UI, unidentifiable.
Incoming clinical E. coli samples, collected over a three-month period for routine serotyping, were selected and MS-H was performed independently without motility induction; bPCR-based DNA sequencing carried out for confirmation of H21.
Side-by-side comparison of H serotyping and MS-H typing of E. coli H types with the Orbitrap platforma.
| Strain Number | Previously recorded H-types with induced motility | Serotyping without induced motility | MS-H | Sequence coverage (%) | ||
| Day 1 | Day 2 | Day 3 | ||||
| 06-4319 | H7 | H7 | H7 | 54 | 62 | 87 |
| 06-1139 | H7 | – | H7 | 87 | 84 | 87 |
| 07-1591 | H7 | – | H7 | 93 | 89 | 81 |
| 07-1756 | H7 | – | H7 | 85 | 87 | 87 |
| EDL933 | H7 | H7 | H7 | 90 | 71 | 88 |
| 90-2380 | H7 | – | H7 | 85 | 83 | 90 |
| 05-0958 | H7 | – | H7 | 81 | 62 | 88 |
| 09-0414 | H7 | – | H7 | 94 | 79 | 89 |
| 09-1349 | H7 | – | H7 | 94 | 88 | 90 |
| 09-1350 | H7 | – | H7 | 91 | 73 | 90 |
| 09-1351 | H7 | – | H7 | 77 | 72 | 88 |
| 09-1352 | H7 | – | H7 | 90 | 83 | 88 |
| E169 | H1 | H1 | H1 | 98 | 83 | 83 |
| E170 | H2 | H2 | H2 | 67 | 71 | 68 |
| E171 | H3 | – | H3 | 92 | 90 | 86 |
| E172 | H4 | H4 | H4 | 89 | 99 | 88 |
| E173 | H5 | – | H5 | 81 | 76 | 58 |
| E174 | H6 | H6 | H6 | 90 | 80 | 63 |
| E176 | H8 | – | H8 | 90 | 90 | 77 |
| E177 | H9 | H9 | H9 | 80 | 77 | 80 |
| E659 | H10 | – | H10 | 99 | 79 | 85 |
| 07-6285 | H11 | – | H11 | 85 | 84 | 80 |
| E241 | H12 | – | – | – | – | – |
| E241Mb | H12 | H12 | H12 | 98 | 97 | 97 |
| E752 | H12 | – | H12 | 98 | 91 | 97 |
| E182 | H14 | H14 | H14 | 47 | 81 | 55 |
| E183 | H15 | H15 | H15 | 73 | 81 | 79 |
| E184 | H16 | – | H16 | 64 | 81 | 77 |
| E185 | H17 | – | H17 | 74 | 85 | 84 |
| E186 | H18 | H18 | H18 | 58 | 68 | 65 |
| 09-0523 | H19 | H19 | H19 | 66 | 89 | 88 |
| E188 | H20 | H20 | H20 | 81 | 73 | 81 |
| E189 | H21 | H21 | H21 | 95 | 98 | 95 |
| E191 | H23 | H23 | H23 | 65 | 67 | 79 |
| E192 | H24 | H24 | H24 | 72 | 65 | 74 |
| E193 | H25 | H25 | H25 | 66 | 73 | 68 |
| E194 | H26 | H26 | H26 | 98 | 75 | 85 |
| E195 | H27 | H27 | H27 | 71 | 63 | 69 |
| E196 | H28 | – | H28 | 70 | 73 | 79 |
| E197 | H29 | H29 | H29 | 83 | 87 | 87 |
| E198 | H30 | – | H30 | 78 | 78 | 79 |
| E199 | H31 | – | H31 | 59 | 40 | 76 |
| E200 | H32 | H32 | H32 | 72 | 42 | 67 |
| E201 | H33 | – | H33 | 70 | 65 | 75 |
| E589 | H34 | H34 | H34 | 65 | 66 | 67 |
| E203 | H35 | – | H35 | 51 | 56 | 45 |
| E204 | H36 | rough | H36 | 90 | 90 | 92 |
| E205 | H37 | – | H37 | 96 | 91 | 85 |
| E206 | H38 | H38 | H38 | 97 | 98 | 86 |
| E207 | H39 | H39 | H39 | 83 | 68 | 61 |
| E208 | H40 | H40 | H40 | 97 | 92 | 91 |
| E209 | H41 | – | H41 | 72 | 47 | 50 |
| E210 | H42 | – | H42 | 48 | – | 36 |
| E210Mb | H42 | H42 | H42 | 72 | 70 | 74 |
| E211 | H43 | – | H43 | 90 | 89 | 89 |
| E212 | H44 | H44 | H44 | 78 | 74 | 76 |
| E213 | H45 | – | H45 | 61 | 60 | 53 |
| E214 | H46 | H46 | H46 | 73 | 68 | 59 |
| E346 | H47 | H47 | H47 | 99 | 83 | 99 |
| E247 | H48 | H48 | H48 | 89 | 91 | 82 |
| E248 | H49 | H49 | H49 | 87 | 87 | 87 |
| E372 | H51 | – | H51 | 84 | 63 | 56 |
| E373 | H52 | – | H52 | 85 | 67 | 59 |
| E374 | H53 | H53 | H53 | 72 | 58 | 74 |
| E377 | H54 | – | H54 | 81 | 68 | 70 |
| E375 | H55 | – | H55 | 63 | – | – |
| E375Mb | H55 | rough | H55 | 71 | 71 | 65 |
| E376 | H56 | – | H56 | 65 | 40 | 53 |
| 09-1760c | Untypeable | H21d | H21 | 97 | 95 | 96 |
-, serotyping titration or MS identification was not reached.
Serotyping and MS-H were performed concurrently from subcultures of single bacterial colonies. MS-H was repeated on two consecutive days; motility induction was performed for these inconsistent strains after initial MS-H; cuntypeable by serotyping although previous MS and PCR-based sequencing showed type H21; dusing designated antisera by MS-H.
Diagnostic specificity, sample stability and run-to-run repeatability test results for MS-H with the Orbitrap platforma.
| Strain number | Previously recorded serotypes with motility induction | MS-H types without motility induction | Sequence coverage (%) | ||
| Run 1 | Run 2 | Run 3 | |||
| 09-1336 | NM | N/A | N/A | N/A | N/A |
| 09-1337 | NM | N/A | N/A | N/A | N/A |
| 09-1338 | NM | N/A | N/A | N/A | N/A |
| 09-1339 | NM | N/A | N/A | N/A | N/A |
| 09-1345 | NM | N/A | N/A | N/A | N/A |
| 09-1346 | NM | N/A | N/A | N/A | N/A |
| 09-0411b | H11 | H11 | 81 | 81 | 81 |
| 09-1342b | H11 | H11 | 83 | 82 | 83 |
| 09-1344b | H11 | H11 | 76 | 74 | 78 |
| 09-1765b | H11 | H11 | 98 | 98 | 91 |
| 09-1767b | H11 | H11 | 93 | 93 | 93 |
| 09-0409 | H28 | H28 | 70 | 79 | 75 |
| 09-0410 | H28 | H28 | 68 | 73 | 74 |
| 09-0416 | H28 | H28 | 76 | 77 | 78 |
| 09-0416 | H28 | H28 | 76 | 77 | 78 |
| 09-0412 | H49 | H49 | 88 | 89 | 89 |
| 09-0413 | H16 | H16 | 74 | 77 | 78 |
| 09-0415 | H8 | H8 | 98 | 91 | 90 |
| 09-1347 | H19 | H19 | 70 | 71 | 75 |
| 09-1348 | H19 | H19 | 67 | 69 | 68 |
| 09-1353 | H25 | H25 | 67 | 70 | 72 |
| 09-1354 | H25 | H25 | 64 | 74 | 78 |
| 09-1770 | H19 | H19 | 81 | 88 | 78 |
| 09-1774 | H19 | H19 | 88 | 88 | 88 |
| 09-1764 | H19 | H19 | 86 | 88 | 82 |
| 09-1766 | H34 | H34 | 59 | 59 | 59 |
| 09-1768 | H14 | H14 | 98 | 98 | 98 |
| 09-1769 | H14 | H14 | 98 | 98 | 98 |
| 09-1775 | H25, then rough | H25 | 76 | 81 | 80 |
NM, non-motile; N/A, not attainable.
The same flagella digest was tested by LC-MS/MS three times within a one-week period; ba two-year old residual digest was re-used.
Comparison of H serotyping and MS-H of E. coli.
| Parameter | H Serotyping | MS-H |
| Diagnostic sensitivity | Could reach 100% | Could reach 100% |
| Diagnostic specificity | Could reach 100% | Could reach 100% |
| Analytical sensitivity | Loop size of culture | 5 colonies |
| Analytical specificity | Antigenic epitope dependent | Ionization dependent |
| Read-out | Agglutination titer observation by eyes; process may require several steps | Protein and peptide sequences analyzed by software; one step identification |
| Motility induction | Routinely required | Not routinely required |
| Rapidity to get result | 3 to 5 days | 4 hr for a single sample |
| Ease of identifying rough strains | Impossible | Possible; motility induction can be used to obtain result |
| Result consistency | Motility induction and antisera dependent | Instrumentation and software dependent |
| Robustness and ruggedness | Limited; largely performed manually; may require optimal antigen/antisera reaction conditions | Good; largely performed by machine; can tolerate wide range of sample amounts and different instruments |
| Throughput | Limited, largely performed manually; not easily repeated | Good; LC-MS/MS can run day and night; easy to repeat and obtain a better result |
| Sample stability | Variation in bacteria growth | Protein digests are stable |
| Consumables and labor used | Antisera, culture media,Craigie tubes; Half day of labor | Trypsin, lysozyme, nano-LC columns; instrument service contract; MS routine runs, half hour of labor |
| System suitability/accessibility | Reference labs/institutions with antiserum or antibody production | Institutions or service labs with MS capability |